In vitro studies with berbamine have shown an increase in the intracellular concentration of adriamycin and down-regulation of MDR1 mRNA and P-gp levels in a human leukemic cell line, K562/A02 [35] as well as in a human breast cancer cell line, MCF7 [37]. The gene discussed is ABCB1; the disease is breast cancer.